SEQUOIA LOG (SEQL3) Main Indicators
Basic Data - SEQL3
| Company | SEQUOIA LOG |
| Corporate Name | SEQUOIA LOGISTICA E TRANSPORTES S.A |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Logística.transporte rodoviário de cargas em geral. municipal. intermunicipal. estadual e interestadual. serviços de entrega rápida e carga e descarga. dentre outros. |
| Share | SEQL3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 3.75 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 4.88 M |
| Last Statement | ITR - 06/30/2024 |
| Sector | Bens Industriais |
| Subsector | Serviços |
| Segment | Serviços Diversos |
| Participation Indexes | IBRA, IGC, IGCT, IGNM, ITAG, SMLL |
| Updated 11/21/2024 | |
Relative Prices - SEQL3
| Price/Earnings | -0.11 |
| Price/SBV | 0.14 |
| Price/Net Sales | 0.14 |
| Price/CFO | -0.77 |
| Price/FCF | -0.77 |
| Price/Total Assets | 0.04 |
| Price/EBIT | -0.13 |
| Price/Working Capital | -0.21 |
| Price/NCAV | -0.05 |
| EV/EBIT | -0.90 |
| EV/EBITDA | -1.15 |
| EV/Net Sales | 0.99 |
| EV/CFO | -5.46 |
| EV/FCF | -5.43 |
| EV/Total Assets | 0.30 |
| Company Market Cap | R$ 85.52 M |
| Enterprise Value | R$ 603.60 M |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 3.75 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 0.00% |
| Updated 11/21/2024 | |
Income Statement - SEQL3
| Net Revenue | R$ 609.12 M |
| Gross Result | - R$ 70.15 M |
| EBIT | - R$ 669.83 M |
| Depreciation and Amortization | - R$ 146.40 M |
| EBITDA | - R$ 523.43 M |
| Net Profit | - R$ 814.14 M |
| Net Profit/Share | - R$ 40.63 |
| Updated 08/13/2024 | |
| Net Revenue | R$ 243.41 M |
| Gross Result | R$ 11.83 M |
| EBIT | - R$ 56.60 M |
| Depreciation and Amortization | - R$ 38.65 M |
| EBITDA | - R$ 17.95 M |
| Net Profit | - R$ 118.80 M |
| Profit/Share | - R$ 5.93 |
| Updated 08/13/2024 | |
Price and Volume Behavior - SEQL3
| Lowest Price 52 weeks | R$ 3.05 |
| Highest Price 52 weeks | R$ 15.80 |
| Variation 2024 | -76.27% |
| Variation 1 year | -62.50% |
| Variation 2 years(total) | -94.55% |
| Variation 2 years(yearly) | -76.56% |
| Variation 3 years(total) | -98.49% |
| Variation 3 years(yearly) | -75.25% |
| Variation 4 years(total) | -98.90% |
| Variation 4 years(yearly) | -67.59% |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 4.89 M |
| Updated 11/21/2024 | |
Returns and Margins - SEQL3
| Return on Initial Tangible Capital | -86.85% |
| Return on Initial Invested Capital | -34.58% |
| Pre-Tax Return on Initial Tangible Capital | -131.59% |
| Pre-Tax Return on Initial Invested Capital | -52.39% |
| Return on Initial Shareholder´s Equity | -224.52% |
| Return on Initial Asset | -43.01% |
| Gross Margin | -11.52% |
| Net Margin | -133.66% |
| EBIT Margin | -109.97% |
| EBITDA Margin | -85.93% |
| Initial Asset Turnover | 0.32 |
| Financial Leverage | 3.36 |
| Liabilities/Net Worth | 2.36 |
| Net Debt/EBITDA | -0.99 |
| Updated 08/13/2024 | |
Balance Sheet - SEQL3
| Cash and Cash Equivalents | R$ 44.20 M |
| Total Assets | R$ 1.99 B |
| Short-Term Debt | R$ 259.75 M |
| Long-Term Debt | R$ 302.53 M |
| Gross Debt | R$ 562.28 M |
| Net Debt | R$ 518.08 M |
| Shareholder´s Equity | R$ 593.88 M |
| Share Book Value | R$ 29.64 |
| Common Shares | 20,039,539 |
| Preferred Shares | 0 |
| Total | 20,039,539 |
| Common Shares in Treasury | 0 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 0 |
| Common Shares (Except Treasury) | 20,039,539 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 20,039,539 |
| Updated 08/13/2024 | |
Cash Flow - SEQL3
| Operating Cash Flow | - R$ 110.64 M |
| Cash Flow from Investments | - R$ 37.51 M |
| Financing Cash Flow | R$ 100.58 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 47.58 M |
| Updated 08/13/2024 | |
| Operating Cash Flow | R$ 25.92 M |
| Cash Flow from Investments | - R$ 20.00 thousand |
| Financing Cash Flow | - R$ 4.64 M |
| Increase (Reduction) in Cash and Equivalents | R$ 21.27 M |
| Updated 08/13/2024 | |
Experimental - SEQL3
| CAPEX 3 months | - R$ 20.00 thousand |
| Free Cash Flow 3 months | R$ 25.90 M |
| CAPEX 12 months | - R$ 432.00 thousand |
| Free Cash Flow 12 months | - R$ 111.08 M |
| Updated 08/13/2024 | |